Wall Boulevard continues to be jittery on GLP-1s
Wall Boulevard’s considerations about GLP-1s’ affect on scientific tool makers was once again in complete swing after glucose tracking tool supplier Dexcom (DXCM) slashed its full-year steerage after an profits omit final